Negative regulators of cytokine signal transduction

Cellular and Molecular Life Sciences

Volumn 55, Issue 12, 1999, Pages 1568-1577

  Hilton, D J ^a  

^a ROYAL MELBOURNE HOSPITAL   (Australia)

Author keywords

Cytokines; Negative regulation; Signal transduction

Indexed keywords

CYTOKINE; PHOSPHATASE; PHOSPHOTRANSFERASE; PROTEIN INHIBITOR; STAT1 PROTEIN;

AMINO TERMINAL SEQUENCE; KNOCKOUT MOUSE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; CYTOKINES; DOWN-REGULATION; HUMANS; REPRESSOR PROTEINS; SIGNAL TRANSDUCTION; SRC HOMOLOGY DOMAINS;

EID: 0032827081     PISSN: 1420682X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s000180050396     Document Type: Review

References (47)

1. Nicola N. A. (1994) An introduction to the cytokines. In: Guidebook to cytokines and Their Receptors, Nicola N. A. (ed.), pp. 1-7, Oxford University Press, New York
2. Hilton D. J. (1994) An introduction to cytokine receptors. In: Guidebook to Cytokines and their Receptors, Nicola N. A. (ed.), pp. 8-16, Oxford University Press, New York
3. Darnell J. E. Jr (1997) STATs and gene regulation. Science 277: 1630-1635
4. Darnell J. E. Jr. Kerr I. M. and Stark G. R. (1994) Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science 264: 1415-1421
5. Ihle J. N., Witthuhn B. A., Quelle F. W., Yamamoto K., Thierfelder W. E., Kreider B. et al. (1994) Signaling by the cytokine receptor superfamily: JAKs and STATs. Trends Biochem. Sci. 19: 222-227
6. Leonard W. J. and O'Shea J. J. (1998) Jaks and STATs: biological implications. Annu. Rev. Immunol. 16: 293-322
7. Schindler C. and Darnell J. E. Jr (1995) Transcriptional responses to polypeptide ligands: the JAK-STAT pathway. Annu. Rev. Biochem. 64: 621-651
8. Bach E. A., Aguet M. and Schreiber R. D. (1997) The IFN gamma receptor: a paradigm for cytokine receptor signaling. Annu. Rev. Immunol. 15: 563-591
9. Billiau A. (1996) Interferon-gamma: biology and role in pathogenesis. Adv. Immunol. 62: 61-130
10. Endo T. A., Masuhara M., Yokouchi M., Suzuki R., Sakamoto H., Mitsui K. et al. (1997) A new protein containing an SH2 domain that inhibits JAK kinases. Nature 387: 921-924
11. Naka T., Narazaki M., Hirata M., Matsumoto T., Minamoto S., Aono A. et al. (1997) Structure and function of a new STAT-induced STAT inhibitor. Nature 387: 924-929
12. Starr R., Willson T. A., Viney E. M., Murray L. J., Rayner J. R., Jenkins B. J. et al. (1997) A family of cytokine-inducible inhibitors of signalling. Nature 387: 917-921
13. Yoshimura A., Ohkubo T., Kiguchi T., Jenkins N. A., Gilbert D. J., Copeland N. G. et al. (1995) A novel cytokine-inducible gene CIS encodes an SH2-containing protein that binds to tyrosine-phosphorylated interleukin 3 and erythropoietin receptors. EMBO J. 14: 2816-2826
14. Hilton D. J., Richardson R. T., Alexander W. S., Viney E. M., Willson T. A., Sprigg N. S. et al. (1998) Twenty proteins containing a C-terminal SOCS box form five structural classes. Proc. Natl. Acad. Sci. USA 95: 114-119
15. Nicholson S. E., Willson T. A., Starr R., Zhang J.-G., Baca M., Alexander W. S. et al. (1999) Mutational analyses of the SOCS proteins suggest a dual domain requirement but distinct mechanisms for inhibiton of LIF and IL-6 signal transduction. EMBO J. 18: 375-385
16. Matuoka K., Miki H., Takahashi K. and Takenawa T. (1997) A novel ligand for an SH3 domain of the adaptor protein Nek bears an SH2 domain and nuclear signaling motifs. Biochem. Biophys. Res. Commun. 239: 488-492
17. Adams T. E., Hansen J. A., Starr R., Nicola N. A., Hilton D. J. and Billestrup N. (1998) Growth hormone preferentially induces the rapid, transient expression of SOCS-3, a novel inhibitor of cytokine receptor signaling. J. Biol. Chem. 273: 1285-1287
18. Bjorbaek C., Elmquist J. K., Frantz J. D., Shoelson S. E. and Flier J. S. (1998) Identification of SOCS-3 as a potential mediator of central leptin resistance. Mol. Cell 1: 619-625
19. Ito S., Ansari P., Sakatsume M., Dickensheets H., Vasquez N., Donnelly R. P. et al. (1999) Interleukin-10 inhibits expression of both interferon α- and interferon α-induced genes by suppressing tyrosine phosphorylation of STAT1. Blood 93: 1-9
20. Masuhara M., Sakamoto H., Matsumoto A., Suzuki R., Yasukawa H., Mitsui K. et al. (1997) Cloning and characterization of novel CIS family genes. Biochem. Biophys. Res. Commun. 239: 439-446
21. Sakamoto H., Yasukawa H., Masuhara M., Tanimura S., Sasaki A., Yuge K. et al. (1998) A Janus kinase inhibitor, JAB, is an interferon-gamma-inducible gene and confers resistance to interferons. Blood 92: 1668-1676
22. Song M. M. and Shuai K. (1998) The suppressor of cytokine signalling (SOCS) 1 and SOCS3 but not SOCS proteins inhibit interferon-mediated antiviral and antiproliferative activities. J. Biol. Chem. 273: 35056-35062
23. Mui A. L., Wakao H., Kinoshita T., Kitamura T. and Miyajima A. (1996) Suppression of interleukin-3-induecd gene expression by a C-terminal truncated Stat5: role of Stat5 in proliferation. EMBO J. 15: 2425-2433
24. Teglund S., McKay C., Schuetz E., Deursen J. M. van, Stravopodis D., Wang D. et al. (1998) Stat5a and Stat5b proteins have essential and nonessential, or redundant, roles in cytokine responses. Cell 93: 841-850
25. Matsumoto A., Masuhara M., Mitsui K., Yokouchi M., Ohtsubo M., Misawa H. et al. (1997) CIS, a cytokine inducible SH2 protein, is a target of the JAK-STAT5 pathway and modulates STAT5 activation. Blood 89: 3148-3154
26. Durbin J. E., Hackenmiller R., Simon M. C. and Levy D. E. (1996) Targeted disruption of the mouse Stat1 gene results in compromised innate immunity to viral disease. Cell 84: 443-450
27. Meraz M. A., White J. M., Sheehan K. C., Bach E. A., Rodig S. J., Dighe A. S. et al. (1996) Targeted disruption of the Stat1 gene in mice reveals unexpected physiologic specificity in the JAK-STAT signaling pathway. Cell 84: 431-442
28. Naka T., Matsumoto T., Narazaki M., Fujimoto M., Morita Y., Ohsawa Y. et al. (1998) Accelerated apoptosis of lymphocytes by augmented induction of Bax in SSI-1 (STAT-induced STAT inhibitor-1) deficient mice. Proc. Natl. Acad. Sci. USA 95: 15577-15582
29. Verdier F., Chretien S., Muller O., Varlet P., Yoshimura A., Gisselbrecht S. et al. (1998) Proteasomes regulate erythropoietin receptor and signal transducer and activator of transcription 5 (STAT5) activation. J. Biol. Chem. 273: 28185-28190
30. Narazaki M., Fujimoto M., Matsumoto M., Morita Y., Saito H., Kajita T. et al. (1998) Three distinct domains of SSI-1/ SOCS-1/JAB protein are required for its suppression of interleukin 6 signalling. Proc. Natl. Acad. Sci. USA 95: 13130-13134
31. Kamura T., Sato S., Haque D., Kaelin W. G., Conaway R. C. and Conaway J. W. (1998) The elongin BC complex interacts with the conserved SOCS-box motif present in members of the SOCS, ras, WD-40 repeat and ankyrin repeat families. Genes Dev. 12: 3872-3881
32. Zhang J.-G., Farley A., Nicholson S. E., Willson T. A., Zugaro L. M., Simpson R. J. et al. (1999) The conserved SOCS box motif in suppressors of cytokine signalling binds to elongins B and C and may couple proteins to proteosomal degradation. Proc. Natl. Acad. Sci. USA 96: 2071-2076
33. Chung C. D., Liao J., Liu B., Rao X., Jay P., Berta P. et al. (1997) Specific inhibition of Stat3 signal transduction by PIAS3. Science 278: 1803-1805
34. Liu B., Liao J., Rao X., Kushner S. A., Chung C. D., Chang D. D. et al. (1998) Inhibition of Stat1-mediated gene activation by PIAS1. Proc. Natl. Acad. Sci. USA 95: 10626-10631
35. Shultz, L. D., Rajan T. V. and Greiner D. L. (1997) Severe defects in immunity and hematopoiesis caused by SHP-1 protein-tyrosine-phosphatase deficiency. Trends Biotechnol. 15: 302-307
36. Chen H. E., Chang S., Trub T. and Neel B. G. (1996) Regulation of colony-stimulating factor 1 receptor signaling by the SH2 domain-containing tyrosine phosphatase SH-PTP1. Mol. Cell. Biol. 16: 3685-3697
37. Paulson R. F., Vesely S., Siminovitch K. A. and Bernstein A. (1996) Signalling by the W/Kit receptor tyrosine kinase is negatively regulated in vivo by the protein tyrosine phosphatase Shpl. Nat. Genet. 13: 309-315
38. Jiao H., Berrada K., Yang W., Tabrizi M., Platanias L. C. and Yi T. (1996) Direct association with and dephosphorylation of Jak2 kinase by the SH2-domain-containing protein tyrosine phosphatase SHP-1. Mol. Cell Biol. 16: 6985-6992
39. Jiao H., Yang W., Berrada K., Tabrizi M., Shultz L. and Yi T. (1997) Macrophages from motheaten and viable motheaten mutant mice show increased proliferative responses to GM-CSF: detection of potential HCP substrates in GM-CSF signal transduction. Exp. Hematol. 25: 592-600
40. Takahashi K., Miyakawa K., Wynn A. A., Nakayama K. I., Myint Y. Y., Naito M. et al. (1998) Effects of granulocyte macrophage colony-stimulating factor on the development and differentiation of CD5-positive macrophages and their potential derivation from a CD5-positive B-cell lineage in mice. Am. J. Pathol. 152: 445-456
41. David M., Chen H. E., Goelz S., Larner A. C. and Neel B. G. (1995) Differential regulation of the alpha/beta interferon-stimulated Jak/Stat pathway by the SH2 domain-containing tyrosine phosphatase SHPTP1. Mol. Cell. Biol. 15: 7050-7058
42. Yetter A., Uddin S., Krolewski J. J., Jiao H., Yi T. and Platanias L. C. (1995) Association of the interferon-dependent tyrosine kinase Tyk-2 with the hematopoietic cell phosphatase. J. Biol. Chem. 270: 18179-18182
43. Yoshimura A., Longmore G. and Lodish H. F. (1990) Point mutation in the exoplasmic domain of the erythropoietin receptor resulting in hormone-independent activation and tumorigenicity. Nature 348: 647-649
44. Van Zant G. and Shultz L. (1989) Hematologic abnormalities of the immunodeficient mouse mutant, viable motheaten (mev). Exp. Hematol. 17: 81-87
45. Klingmuller U., Lorenz U., Cantley L. C., Neel B. G. and Lodish H. F. (1995) Specific recruitment of SH-PTP1 to the erythropoietin receptor causes inactivation of JAK2 and termination of proliferative signals. Cell 80: 729-738
46. Chapelle A. de la, Sistonen P., Lehvaslaiho H., Ikkala E. and Juvonen E. (1993) Familial erythrocytosis genetically linked to erythropoietin receptor gene. Lancet 341: 82-84
47. Furukawa T., Narita M., Sakaue M., Otsuka T., Kuroha T., Masuko M. et al. (1997) Primary familial polycythaemia associated with a novel point mutation in the erythropoietin receptor. Br. J. Haematol. 99: 222-227